Skip Navigation

Resources

Recommendation
Updated Jan 6, 2010
An audio interview with Vivek Mehta, radiation oncology expert, on the subject of brain metastases and prophylactic cranial irradiation in the setting of lung cancer. This interview is part of a s... more
Recommendation
Updated Jan 6, 2010
Acrobat
Uploaded Jan 5, 2010
The general concepts of management of brain metastases, a subject that is still evolving because of our growing technology, particularly with stereotactic radiosurgery (SRS), commonly referred to ... more
Acrobat
Uploaded Jan 5, 2010
While brain metastases are common, some patients seem to be at higher risk than others.
Acrobat
Uploaded Jan 5, 2010
We’ll cover the special situation of the patient who has a brain metastasis identified as the ONLY area of metastatic disease (generally referring to NSCLC, since SCLC has such a high tendency to s... more
Acrobat
Uploaded Jan 5, 2010
Up to a few years ago, whole brain radiation therapy (WBRT) was the clear standard intervention for patients with lung cancer and brain metastases.
Acrobat
Uploaded Jan 5, 2010
A diagnosis of brain metastases has to be one of the most scary and disappointing of all potholes on the cancer journey. It is unfortunately common, happening to about 170,000 new patients each yea... more
Acrobat
Uploaded Jan 5, 2010
MD Anderson Cancer Center presented their study on whole brain radiation vs. stereotactic radiation for 1-3 brain metastases as part of the plenary session, and I wanted to review it with you here ... more
Acrobat
Uploaded Jan 5, 2010
Re-treatment of brain metastases is one of the most difficult of cancer treatment problems. It is also an area where the art of medicine supersedes the science by a long way.
Acrobat
Uploaded Jan 5, 2010
Inhibitors of the epidermal growth factor receptor (EGFR), such as Iressa (gefitinib) and Tarceva (erlotinib) are generally known for being often minimally toxic, oral, targeted therapies that can ... more
Acrobat
Uploaded Jan 5, 2010
There’s a general concept out there that chemo is ineffective in treating brain metastases...